Vise Technologies Inc. Has $2.84 Million Stock Holdings in Elevance Health, Inc. $ELV

Vise Technologies Inc. grew its position in Elevance Health, Inc. (NYSE:ELV) by 20.2% during the 4th quarter, Holdings Channel reports. The firm owned 8,088 shares of the company’s stock after purchasing an additional 1,359 shares during the quarter. Vise Technologies Inc.’s holdings in Elevance Health were worth $2,835,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in ELV. Norges Bank bought a new position in shares of Elevance Health in the fourth quarter valued at about $1,058,165,000. Bank of New York Mellon Corp raised its holdings in shares of Elevance Health by 79.3% in the fourth quarter. Bank of New York Mellon Corp now owns 2,408,704 shares of the company’s stock valued at $844,371,000 after buying an additional 1,065,065 shares during the last quarter. Artisan Partners Limited Partnership raised its holdings in shares of Elevance Health by 24.5% in the third quarter. Artisan Partners Limited Partnership now owns 4,576,805 shares of the company’s stock valued at $1,478,857,000 after buying an additional 901,626 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of Elevance Health by 25.0% in the third quarter. First Eagle Investment Management LLC now owns 3,998,603 shares of the company’s stock valued at $1,292,029,000 after buying an additional 798,457 shares during the last quarter. Finally, Brave Warrior Advisors LLC raised its holdings in shares of Elevance Health by 65.3% in the third quarter. Brave Warrior Advisors LLC now owns 1,834,002 shares of the company’s stock valued at $592,603,000 after buying an additional 724,349 shares during the last quarter. 89.24% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Bank of America lifted their price target on Elevance Health from $435.00 to $460.00 and gave the company a “buy” rating in a report on Thursday. Truist Financial lifted their price target on Elevance Health from $375.00 to $450.00 and gave the company a “buy” rating in a report on Monday, June 1st. Leerink Partners set a $364.00 price target on Elevance Health in a report on Thursday, April 23rd. Citigroup raised Elevance Health to a “buy” rating in a report on Wednesday, April 29th. Finally, Jefferies Financial Group cut their price target on Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a report on Monday, April 20th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $411.11.

Elevance Health Price Performance

Elevance Health stock opened at $415.88 on Friday. The firm has a market capitalization of $90.31 billion, a P/E ratio of 17.69, a PEG ratio of 2.35 and a beta of 0.67. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $416.56. The business has a 50-day moving average of $354.74 and a 200-day moving average of $341.76. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last posted its earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The company’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company earned $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. On average, equities analysts anticipate that Elevance Health, Inc. will post 26.94 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be given a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s payout ratio is presently 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.